Beam Therapeutics Inc. (BEAM)
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.
Address
26 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
Founded
2017
Number of Employees
436
Website
http://www.beamtx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)